Key Market Indicators
**Israeli Vaccination Coverage Remains Steady for Second Year** In 2023, Israel maintained a high vaccination coverage with 99% of children aged one year old, mirroring the same rate from 2022. This consistency highlights the country's robust immunization program, which has seen only a slight increase of 0.2 percentage points annually since 1985. **Vaccine Imports on the Rise** Israel's vaccine imports are projected to climb to approximately $102 million by 2028, up from around $88 million in 2023. This represents an average annual growth rate of 2.1%. Since the turn of the century, the demand for vaccines in Israel has grown at an average rate of 4% per year. **Modest Growth in Vaccine Exports** On the export front, Israel's vaccine exports are expected to reach about $18 million by 2028, increasing from nearly $16 million in 2023. This growth reflects a compound annual growth rate (CAGR) of 1.5%. However, since 2001, the country's vaccine supply has seen a yearly decrease of 2%. In 2023, Israel ranked 26th in global vaccine exports, with Denmark slightly ahead at the same export value of $16 million. Leading the pack were Belgium, the United Kingdom, and France, securing the top three positions in this sector.
